文献速递精神分裂症与精神病性障碍

精神分裂症丘脑多巴胺D2受体可用性:一项抗精神病药初治首发精神病患者研究及荟萃分析

Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis.
PubMed 文献 · Mol Psychiatry · 2021-11-10

本研究采用高分辨率PET及高亲和力D2受体放射性配体[11C]FLB457,比较19例抗精神病药初治首发精神病患者与19名年龄性别匹配健康对照的丘脑D2受体结合潜力,发现患者全丘脑及丘脑-额叶皮层连接区BPND较低,荟萃分析(含本研究样本)证实患者丘脑D2受体可用性显著降低,探索性分析提示患者下丘脑辐射各向异性分数较低。

要点

  • 抗精神病药初治首发精神病患者全丘脑D2受体BPND较对照降低(Cohen's dz=-0.479,p=0.026,BF>4)。
  • 丘脑-额叶皮层连接区BPND降低(Cohen's dz=-0.527,p=0.017,BF>6)。
  • 含本研究样本的荟萃分析证实患者丘脑D2受体可用性显著降低。

核心结论

  • 研究结果支持精神分裂症存在丘脑多巴胺能神经传递失调的假说,并推测这可能是丘脑皮层连接障碍的基础。

研究设计与样本

  • 研究纳入19例抗精神病药初治首发精神病患者和19名年龄性别匹配健康对照,采用高分辨率正电子发射断层扫描(PET)及高亲和力D2受体放射性配体[11C]FLB457检测丘脑D2受体结合潜力(BPND)。
  • 对11例患者和15名对照的亚组进行弥散张量成像(DTI)。
  • 另进行一项荟萃分析,纳入本研究的样本。

主要发现

  • 患者全丘脑D2受体结合较对照降低(Cohen's dz=-0.479,p=0.026,贝叶斯因子(BF)>4)。
  • 患者丘脑-额叶皮层连接区ROI的BPND较对照降低(Cohen's dz=-0.527,p=0.017,BF>6)。
  • 探索性分析提示患者下丘脑辐射的各向异性分数较对照降低(Cohen's d=-0.692,p=0.036)。
  • 包含本研究样本的荟萃分析证实患者丘脑D2受体可用性显著降低。

局限性

  • DTI分析仅在11例患者和15名对照的亚组中进行。
  • DTI结果为探索性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pharmacological and genetic evidence support a role for an involvement of the dopamine D2-receptor (D2-R) in the pathophysiology of schizophrenia. Previous molecular imaging studies have suggested lower levels of D2-R in thalamus, but results are inconclusive. The objective of the present study was to use improved methodology to compare D2-R density in whole thalamus and thalamic subregions between first-episode psychosis patients and healthy controls. Differences in thalamocortical connectivity was explored based on the D2-R results. 19 antipsychotic-naive first-episode psychosis patients and 19 age- and sex-matched healthy controls were examined using high-resolution Positron Emission Tomography (PET) and the high-affinity D2-R radioligand [11C]FLB457. The main outcome was D2-R binding potential (BPND) in thalamus, and it was predicted that patients would have lower binding. Diffusion tensor imaging (DTI) was performed in a subgroup of 11 patients and 15 controls. D2-R binding in whole thalamus was lower in patients compared with controls (Cohen's dz = -0.479, p = 0.026, Bayes Factor (BF) > 4). Among subregions, lower BPND was observed in the ROI representing thalamic connectivity to the frontal cortex (Cohen's dz = -0.527, p = 0.017, BF > 6). A meta-analysis, including the sample of this study, confirmed significantly lower thalamic D2-R availability in patients. Exploratory analyses suggested that patients had lower fractional anisotropy values compared with controls (Cohen's d = -0.692, p = 0.036) in the inferior thalamic radiation. The findings support the hypothesis of a dysregulation of thalamic dopaminergic neurotransmission in schizophrenia, and it is hypothesized that this could underlie a disturbance of thalamocortical connectivity.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Plavén-Sigray P, Ikonen Victorsson P, Santillo A, et al. Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis. Mol Psychiatry. 2021. PMID: 34759359. doi:10.1038/s41380-021-01349-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。